FMR LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$93,386,022
-20.5%
2,057,414
-1.6%
0.01%
-20.0%
Q2 2023$117,398,452
-39.3%
2,091,173
-51.1%
0.01%
+11.1%
Q1 2023$193,499,006
+117.9%
4,278,112
+95.8%
0.01%0.0%
Q4 2022$88,795,210
-36.7%
2,184,384
+1.8%
0.01%
-40.0%
Q3 2022$140,270,000
+42.6%
2,146,444
+32.6%
0.02%
+50.0%
Q2 2022$98,388,000
+24.2%
1,619,022
+28.3%
0.01%
+66.7%
Q1 2022$79,192,000
+181.9%
1,261,622
+240.3%
0.01%
+200.0%
Q4 2021$28,093,000
-56.3%
370,722
-35.5%
0.00%
-60.0%
Q3 2021$64,302,000
-31.1%
574,481
-0.4%
0.01%
-28.6%
Q2 2021$93,367,000
+34.9%
576,727
+1.6%
0.01%
+16.7%
Q1 2021$69,201,000
-50.2%
567,922
-37.4%
0.01%
-50.0%
Q4 2020$138,992,000
+75.2%
907,789
-4.3%
0.01%
+50.0%
Q3 2020$79,328,000
+3.6%
948,453
-9.0%
0.01%0.0%
Q2 2020$76,563,000
+105.8%
1,041,810
+18.8%
0.01%
+60.0%
Q1 2020$37,194,000
-35.9%
877,014
-7.9%
0.01%
-16.7%
Q4 2019$58,004,000
+155.3%
952,369
+71.8%
0.01%
+100.0%
Q3 2019$22,723,000
+61.8%
554,357
+85.9%
0.00%
+50.0%
Q2 2019$14,048,000
+62.3%
298,269
+23.1%
0.00%
+100.0%
Q1 2019$8,656,000
-4.1%
242,336
-23.3%
0.00%0.0%
Q4 2018$9,024,000
-31.9%
315,836
+5.7%
0.00%0.0%
Q3 2018$13,257,000
+14.0%
298,936
+51.0%
0.00%0.0%
Q2 2018$11,629,000197,9080.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders